Moleculent

Culture & Overview

Moleculent is a biotechnology company based in Solna, Sweden, founded in 2021. It focuses on pioneering functional profiling to map cell-cell communication at scale in human tissue. The company has raised $46 million in total funding across two rounds, including a $20 million Series B round in April 2026. Investors include ARCH Venture Partners, EIR Ventures, Rubicon Healthcare Partners, and Subvenio Invest. Moleculent aims to make its technology globally available to translational labs and has seen strong demand from leading research institutions and pharmaceutical partners in Europe and the U.S. - By: Patrick Lavery Moleculent has announced the closing of a $20 million financing round that supports its mission to pioneer functional profiling. Namely, the capital will go toward expansion of Moleculent’s Techstart Early Access Program, supporting commercial launch of the company’s instrument. [...] Moleculent has announced the closing of a $20 million financing round that supports its mission - | | | --- | | Application Date | 6/23/2022 | | Grant Date | 2/18/2025 | | Title | Spatial analysis of a planar biological sample | | Related Topics | Molecular biology, Biotechnology, DNA, Molecular biology techniques, Genetics | | Status | Grant | ## LatestMoleculent News Moleculent Raises $20 Million to Scale its Functional Profiling Platform and Accelerate US Expansion Apr 30, 2026 [...] Ole Da - Moleculent is a biotechnology company developing technology that maps cell-cell communication in human tissue to uncover insights into cellular functions and disease pathways. This platform targets researchers and healthcare professionals tackling complex diseases like cancer and neurodegenerative disorders, addressing the challenge of understanding intricate biological interactions at a tissue le - Moleculent has raised a total funding of $46M over 2 rounds. Its first funding round was on Jun 11, 2024. Its latest funding round was a Series A round on May 01, 2026 for $\\\\\. 3 investors participated in its latest round. Moleculent has 3 institutional investors. [...] | Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score | --- --- --- | | 1st | Logo for Molec